Convenient synthesis of 2,2-disubstituted-2,3-dihydro-1,4-benzodioxins from 2-substituted-2-hydroxy-2,3-dihydro-1,4-benzodioxins
摘要:
Convenient syntheses of relatively rare 2,2-disubstituted-2,3-dihydro-1,4-benzodioxins from 2-substituted-2-hydroxy 2,3-dihydro-1,4-benzodioxins, as key synthetic intermediates, are reported. These new synthetic approaches require Lewis acid BF3-Et(2)O mediated nucleophilic substitution reaction or cyclization of suitable hydroxyphenols. (C) 1997, Elsevier Science Ltd.
Biaryl-methanethio-, -sulphinyl- and sulphonyl derivatives
申请人:CEPHALON, INC.
公开号:EP1586559A1
公开(公告)日:2005-10-19
FIELD OF THE INVENTION
The present invention is related to chemical compositions, processes for the preparation thereof and uses of the composition. Particularly, the present invention relates to compositions that include substituted biaryl-methanesulfinyl acetamides of Formula (I):
wherein Ar, Y, R1, R2, R4, R5, q and x are as defined herein; and their use in the treatment of diseases, including treatment of sleepiness associated with narcolepsy, obstructive sleep apnea, or shift work disorder; Parkinson's disease; Alzheimer's disease; attention deficit disorder; attention deficit hyperactivity disorder; depression; or fatigue associated with a neurological disease; as well as the promotion of wakefulness.
Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
申请人:CEPHALON FRANCE
公开号:EP1589016A1
公开(公告)日:2005-10-26
The present invention is related to chemical compositions, processes for the preparation thereof and uses of the composition. Particularly, the present invention relates to compositions of compounds of Formula (A):
wherein Ar, Y, R1 and q are as defined herein; and their use in the treatment of diseases, including treatment of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, treatment of attention deficit hyperactivity disorder ("ADHD"), enhancing function in disorders associated with hypofunctionality of the cerebral cortex, including, but not limited to, depression, schizophrenia, fatigue, in particular, fatigue associated with neurologic disease, such as multiple sclerosis, chronic fatigue syndrome, and improvement of cognitive dysfunction.
An Ir-catalyzed asymmetric hydrogenation of 2-substituted 1,4-benzodioxines was developed for the preparation of chiral 1,4-benzodioxanes, which are present in numerous biologically active compounds and natural products. Our tropos biphenyl phosphine-oxazoline ligand is essential for obtaining good ee. A broad range of substrates were tolerable to the reaction conditions and gave the corresponding
A versatile catalyst system for enantioselective synthesis of 2-substituted 1,4-benzodioxanes
作者:Eugene Chong、Bo Qu、Yongda Zhang、Zachary P. Cannone、Joyce C. Leung、Sergei Tcyrulnikov、Khoa D. Nguyen、Nizar Haddad、Soumik Biswas、Xiaowen Hou、Katarzyna Kaczanowska、Michał Chwalba、Andrzej Tracz、Stefan Czarnocki、Jinhua J. Song、Marisa C. Kozlowski、Chris H. Senanayake
DOI:10.1039/c8sc05612a
日期:——
We report the synthesis of enantiomerically enriched 1,4-benzodioxanes containing alkyl, aryl, heteroaryl, and/or carbonyl substituents at the 2-position. The starting 1,4-benzodioxines were readily synthesized via ring closing metathesis using an efficient nitro-Grela catalyst at ppm levels. Excellent enantioselectivities of up to 99:1 er were obtained by using the versatile catalyst system [Ir(c
申请人:DOOSAN CORPORATION 주식회사 두산(119987140410) Corp. No ▼ 110111-0013774BRN ▼107-81-00237
公开号:KR20170076113A
公开(公告)日:2017-07-04
본 발명은 신규 화합물 및 이를 포함하는 유기 전계 발광 소자에 관한 것으로서, 본 발명에 따른 화합물은 유기 전계 발광 소자의 유기물층, 바람직하게는 정공 수송층 또는 발광 보조층에 사용됨에 따라 유기 전계 발광 소자의 발광 효율, 구동 전압, 수명 등을 향상시킬 수 있다.